These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35094881)

  • 21. Comparative effectiveness and durability of COVID-19 vaccination against death and severe disease in an ongoing nationwide mass vaccination campaign.
    Lytras T; Kontopidou F; Lambrou A; Tsiodras S
    J Med Virol; 2022 Oct; 94(10):5044-5050. PubMed ID: 35701379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Simulated COVID-19 Vaccination and Nonpharmaceutical Interventions With Infections, Hospitalizations, and Mortality.
    Patel MD; Rosenstrom E; Ivy JS; Mayorga ME; Keskinocak P; Boyce RM; Hassmiller Lich K; Smith RL; Johnson KT; Delamater PL; Swann JL
    JAMA Netw Open; 2021 Jun; 4(6):e2110782. PubMed ID: 34061203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-country evidence on the role of national governance in boosting COVID-19 vaccination.
    Aida T; Shoji M
    BMC Public Health; 2022 Mar; 22(1):576. PubMed ID: 35321676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of COVID-19 vaccination campaigns accounting for antibody-dependent enhancement.
    Adil Mahmoud Yousif N; Tsoungui Obama HCJ; Ngucho Mbeutchou YJ; Kwamou Ngaha SF; Kayanula L; Kamanga G; Ibrahim TB; Bwanu Iliya P; Iyanda S; Alawam Nemer L; Helle KB; Teboh-Ewungkem MI; Schneider KA
    PLoS One; 2021; 16(4):e0245417. PubMed ID: 33886573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low coverage of COVID-19 vaccines in Africa: current evidence and the way forward.
    Lawal L; Aminu Bello M; Murwira T; Avoka C; Yusuf Ma'aruf S; Harrison Omonhinmin I; Maluleke P; Tsagkaris C; Onyeaka H
    Hum Vaccin Immunother; 2022 Dec; 18(1):2034457. PubMed ID: 35240908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.
    Yang W; Shaman J
    medRxiv; 2021 Nov; ():. PubMed ID: 34845460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal SARS-CoV-2 vaccine allocation using real-time attack-rate estimates in Rhode Island and Massachusetts.
    Tran TN; Wikle NB; Albert E; Inam H; Strong E; Brinda K; Leighow SM; Yang F; Hossain S; Pritchard JR; Chan P; Hanage WP; Hanks EM; Boni MF
    BMC Med; 2021 Jul; 19(1):162. PubMed ID: 34253200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global, regional, and national estimates of target population sizes for covid-19 vaccination: descriptive study.
    Wang W; Wu Q; Yang J; Dong K; Chen X; Bai X; Chen X; Chen Z; Viboud C; Ajelli M; Yu H
    BMJ; 2020 Dec; 371():m4704. PubMed ID: 33323388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anatomy of the first six months of COVID-19 vaccination campaign in Italy.
    Gozzi N; Chinazzi M; Davis JT; Mu K; Pastore Y Piontti A; Ajelli M; Perra N; Vespignani A
    PLoS Comput Biol; 2022 May; 18(5):e1010146. PubMed ID: 35613248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing COVID-19 Vaccine Uptake and Effectiveness Through the North West London Vaccination Program: Retrospective Cohort Study.
    Glampson B; Brittain J; Kaura A; Mulla A; Mercuri L; Brett SJ; Aylin P; Sandall T; Goodman I; Redhead J; Saravanakumar K; Mayer EK
    JMIR Public Health Surveill; 2021 Sep; 7(9):e30010. PubMed ID: 34265740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a COVID-19 Vaccine Campaign and SARS-CoV-2 Infection and Mortality Among Adults Aged 60 Years And Older in a Middle-Income Country.
    Macchia A; Ferrante D; Angeleri P; Biscayart C; Mariani J; Esteban S; Tablado MR; de Quirós FGB
    JAMA Netw Open; 2021 Oct; 4(10):e2130800. PubMed ID: 34714342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guidance for Implementing COVID-19 Prevention Strategies in the Context of Varying Community Transmission Levels and Vaccination Coverage.
    Christie A; Brooks JT; Hicks LA; Sauber-Schatz EK; Yoder JS; Honein MA;
    MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(30):1044-1047. PubMed ID: 34324480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Developing a Framework for Pandemic COVID-19 Vaccine Allocation: a Modified Delphi Consensus Study in Korea.
    Choi MJ; Choi WS; Seong H; Choi JY; Kim JH; Kim YJ; Cho EY; Kim DH; Park H; Lee H; Kim NJ; Song JY; Cheong HJ; Kim SI; Peck KR
    J Korean Med Sci; 2021 Jun; 36(23):e166. PubMed ID: 34128597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 vaccines and decreased transmission of SARS-CoV-2.
    Vitiello A; Ferrara F; Troiano V; La Porta R
    Inflammopharmacology; 2021 Oct; 29(5):1357-1360. PubMed ID: 34279767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison between one and two dose SARS-CoV-2 vaccine prioritization for a fixed number of vaccine doses.
    Hill EM; Keeling MJ
    J R Soc Interface; 2021 Sep; 18(182):20210214. PubMed ID: 34465208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitigating the SARS-CoV-2 Delta disease burden in Australia by non-pharmaceutical interventions and vaccinating children: a modelling analysis.
    Milne GJ; Carrivick J; Whyatt D
    BMC Med; 2022 Feb; 20(1):80. PubMed ID: 35177062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.
    Griffin JB; Haddix M; Danza P; Fisher R; Koo TH; Traub E; Gounder P; Jarashow C; Balter S
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1170-1176. PubMed ID: 34437525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effectiveness of Pfizer-BioNTech and Oxford-AstraZeneca Vaccines to Prevent Severe COVID-19 in Costa Rica: Nationwide, Ecological Study of Hospitalization Prevalence.
    Rosero-Bixby L
    JMIR Public Health Surveill; 2022 May; 8(5):e35054. PubMed ID: 35483079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.